Clinical Trial Update: Phase 2a Study to Assess CIVI 007 in Patients on a Background of Statin Therapy [Phase 2]

View source ↗

Summary

Phase 2a trial evaluating CIVI 007 in hypercholesterolemia patients on background statin therapy; results from the study have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• CIVI 007

Snippet

Sponsor: Civi Biopharma, Inc. | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2025-02-13